We are live on ! Find out more
WSL

Western Standard LLC Portfolio holdings

AUM $190M
1-Year Est. Return 40.88%
This Fund
S&P 500
This Quarter Est. Return
-1.71%
1 Year Est. Return
+40.88%
3 Year Est. Return
+68.87%
5 Year Est. Return
+221.93%
10 Year Est. Return
–
AUM
$96.6M
AUM Growth
-$112M
Cap. Flow
-$110M
Cap. Flow %
-113.91%
Top 10 Hldgs %
76.07%
Holding
31
New
7
Increased
9
Reduced
4
Closed
9

Top Buys

Rank Stock Value
1
ZUO
Zuora, Inc.
ZUO
+$7.26M
2
WSC icon
WillScot Mobile Mini Holdings
WSC
+$6.73M
3
PBPB
Potbelly
PBPB
+$5.73M
4
EQC
Equity Commonwealth
EQC
+$5.62M
5
GPGI
GPGI Inc
GPGI
+$2.84M

Top Sells

Rank Stock Value
1
MACK
Merrimack Pharmaceuticals, Inc.
MACK
+$32.1M
2
FIS icon
Fidelity National Information Services
FIS
+$5.32M
3
ORKA
Oruka Therapeutics
ORKA
+$2.48M
4
TPB icon
Turning Point Brands
TPB
+$2.43M
5
VTOL icon
Bristow Group
VTOL
+$2.12M

Sector Composition

Rank Sector Weight
1 Real Estate 19.1%
2 Healthcare 15.87%
3 Energy 15.68%
4 Industrials 14.71%
5 Consumer Discretionary 13.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEOG icon
26
Neogen
NEOG
$2.03B
– –
-72,712
Closed -$1.15M
SPY icon
27
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
– –
-140,000
Closed -$73.2M
TPB icon
28
Turning Point Brands
TPB
$1.52B
– –
-82,978
Closed -$2.43M
VSXY
29
Victoria's Secret
VSXY
$6.78B
– –
-17,700
Closed -$343K
ORKA
30
Oruka Therapeutics
ORKA
$5.44B
– –
-117,512
Closed -$2.48M
MACK
31
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
– –
-2,172,513
Closed -$32.1M
1
2

Similar funds

RCAP
Resolute Capital Asset Partners Denver, Colorado $190M AUM 160.65% 1-Year Est. Return
HCM
Harspring Capital Management New York $190M AUM 19.3% 1-Year Est. Return
CFA
Camarda Financial Advisors Fleming Island, Florida $190M AUM 48.71% 1-Year Est. Return
CCA
Coign Capital Advisors Draper, Utah $190M AUM 12.2% 1-Year Est. Return
G
GuidedMoney Black Earth, Wisconsin $190M AUM
BC
Beaconlight Capital New York $190M AUM 95.82% 1-Year Est. Return
SCM
Sheridan Capital Management San Rafael, California $190M AUM 12.05% 1-Year Est. Return
BCPWM
Bradley & Co Private Wealth Management Miami, Florida $190M AUM 27.45% 1-Year Est. Return

Western Standard LLC's Q2 2024 Portfolio in Review

As of Q2 2024, Western Standard LLC held 31 positions worth $96.6M, down 54% from $209M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Western Standard LLC withdrew a net $110M in Q2 2024, closing 9 positions and reducing 4 holdings. Its most notable exit was Merrimack Pharmaceuticals, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 19% of assets, up from 5% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Western Standard LLC opened a new position in Zuora, Inc. worth $7.5M.

  • Western Standard LLC's largest Q2 2024 buy was Zuora, Inc.: 755,235 shares worth $7.5M.
  • Western Standard LLC added most to Potbelly in Q2 2024, an estimated $5.73M increase.
  • Western Standard LLC's biggest Q2 2024 reduction was Bristow Group, cutting an estimated $2.12M.
  • Western Standard LLC fully exited Merrimack Pharmaceuticals, Inc. in Q2 2024, selling an estimated $32.1M.
  • Western Standard LLC's ten largest holdings make up 76% of its $96.6M portfolio in Q2 2024.
  • Western Standard LLC opened 7 new positions and closed 9 in Q2 2024.
  • Western Standard LLC's portfolio value fell 54% quarter-over-quarter to $96.6M.

Based on Western Standard LLC's 13F filing for Q2 2024, filed 14 Aug 2024.